Delivery Order SPE2DB22D1202-SPE2DB25FVKW4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,961.64 to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract represents a small-value transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be performed at the contractor's corporate headquarters in...
- The Defense Logistics Agency awarded a $4,881.77 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with an ultimate completion date of July 30, 2025. This is a firm fixed price, non-set-aside delivery order placed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. Trulicity, a diabetes medication, represents one of the broad range of pharmaceutical products the company supplies through...
- The Defense Logistics Agency awarded a $1,619.84 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units). This firm fixed-price contract, with an ultimate completion date of August 20, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made without...
- The Defense Logistics Agency awarded a $1,762.92 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 7, 2025, with completion targeted for August 8, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a injectable medication used in diabetes management, reflecting the pharmaceutical distributor's core role in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Trulicity 0.75 mg/0.5 mL pens on July 24, 2025. The contract, valued at $1,889.60 with a firm fixed price structure, represents a single delivery order under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). This award was competitively made with no set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $1,051.05 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 11, 2025, with an ultimate completion date of August 12, 2025. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $7,155.24 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a completion date of September 11, 2025. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a $1,802.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), with an ultimate completion date of August 25, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a $1,501.50 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens with an ultimate completion date of August 5, 2025. This non-set-aside contract employs firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVKW4Delivery Order
The Defense Logistics Agency awarded a $34,772.86 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a completion date of September 11, 2025. This firm fixed price contract, which is not set-aside and was competitively awarded, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes management medication commonly utilized within federal healthcare systems, including military and veteran care networks supported by the Defense Health Agency. This delivery order is executed under AmerisourceBergen Drug Corp's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical, designated SPE2DX and extending through December 2026. This prime contract vehicle enables the company to supply a broad portfolio of pharmaceutical products and medical supplies globally to support military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to fulfill federal procurement requirements through open competition across multiple therapeutic domains, positioning it as a critical vendor within the federal medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.8k | 9/10/25 |